Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of DGPR1008 intraoperative imaging during robot-assisted radical prostatectomy
CTR20253022Phase 2Completed
- Sponsor
- Xindou Biotechnology
- Start
- Sep 2025
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DGPR1008 in prostate cancer (PCa), sponsored by Xindou Biotechnology. Started Sep 2025; status: completed.
02
Drugs
DGPR1008
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20253022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253022.